PGR and neoplasm: Although the compatibility between the measured mRNA expression fold changes (tumor vs. adjacent normal tissue) and the PR IHC status is high (70% of the PR up-regulated tumors were defined as PR IHC-positive, and 75% of the PR down-regulated tumors were defined as PR IHC-negative, see Supplementary Table 1), not all samples follow this pattern.